U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 122

1.
Real world study of the continuation of bevacizumab beyond disease progression after first‐line treatment containing bevacizumab in Chinese patients with advanced non‐small cell lung cancer
Puyuan Xing, Yuxin Mu, Yan Wang, Xuezhi Hao, Yixiang Zhu, Xingsheng Hu, Hongyu Wang, Peng Liu, Lin Lin, Zhijie Wang, Junling Li
Thorac Cancer. 2018 Dec; 9(12): 1716–1724. Published online 2018 Oct 16. doi: 10.1111/1759-7714.12886
PMCID:
PMC6275823
AbstractArticlePDF–941K
2.
24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling
Florent Baty, Markus Joerger, Martin Früh, Dirk Klingbiel, Francesco Zappa, Martin Brutsche
J Transl Med. 2017; 15: 66. Published online 2017 Mar 30. doi: 10.1186/s12967-017-1174-z
PMCID:
PMC5372268
AbstractArticlePDF–2.5M
3.
Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer
Nicolas Pécuchet, Pierre Laurent-Puig, Audrey Mansuet-Lupo, Antoine Legras, Marco Alifano, Karine Pallier, Audrey Didelot, Laure Gibault, Claire Danel, Pierre-Alexandre Just, Marc Riquet, Françoise Le Pimpec-Barthes, Diane Damotte, Elisabeth Fabre, Hélène Blons
Oncotarget. 2017 Apr 4; 8(14): 23831–23840. Published online 2015 Nov 25. doi: 10.18632/oncotarget.6379
PMCID:
PMC5410347
AbstractArticlePDF–1.2M
4.
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations
Stefano Frega, Martina Lorenzi, Matteo Fassan, Stefano Indraccolo, Fiorella Calabrese, Adolfo Favaretto, Laura Bonanno, Valentina Polo, Giulia Zago, Francesca Lunardi, Ilaria Attili, Alberto Pavan, Massimo Rugge, Valentina Guarneri, PierFranco Conte, Giulia Pasello
Oncotarget. 2017 May 16; 8(20): 32626–32638. Published online 2017 Mar 6. doi: 10.18632/oncotarget.15945
PMCID:
PMC5464815
AbstractArticlePDF–1.6M
5.
Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status
Hong Jian, Wei Li, Zhiyong Ma, Jianjin Huang, Jifeng Feng, Yong Song, Beili Gao, Huili Zhu, Min Tao, Chong Bai, Shenglin Ma, Hongming Pan, Shukui Qin, Dong Hua, Yongfeng Yu, Shun Lu
Sci Rep. 2017; 7: 8483. Published online 2017 Aug 16. doi: 10.1038/s41598-017-08399-8
PMCID:
PMC5559626
AbstractArticlePDF–1.5M
6.
Systemic therapy treatment patterns in patients with advanced non‐small cell lung cancer (NSCLC): PIvOTAL study
J. de Castro, P. Tagliaferri, V.C.C. de Lima, S. Ng, M. Thomas, A. Arunachalam, X. Cao, S. Kothari, T. Burke, H. Myeong, A. Grattan, D.H. Lee
Eur J Cancer Care (Engl) 2017 Nov; 26(6): e12734. Published online 2017 Jul 27. doi: 10.1111/ecc.12734
PMCID:
PMC5697695
AbstractArticlePDF–585K
7.
Correlation Between Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphisms and Pemetrexed Chemotherapy Efficacy/Toxicity in Non-Squamous Non-Small Cell Lung Cancer
Gaochen Lan, Lin Lin, Xiong Chen, Libin Chen, Xi Chen
Med Sci Monit. 2017; 23: 5683–5689. Published online 2017 Nov 29. doi: 10.12659/MSM.904836
PMCID:
PMC5718261
AbstractArticlePDF–313K
8.
Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer
Toshihiko Kaneda, Hiroshige Yoshioka, Motohiro Tamiya, Akihiro Tamiya, Akito Hata, Asukaka Okada, Takashi Niwa, Takayuki Shiroyama, Masaki Kanazu, Tadashi Ishida, Nobuyuki Katakami
BMC Cancer. 2018; 18: 6. Published online 2018 Jan 2. doi: 10.1186/s12885-017-3952-7
PMCID:
PMC5749021
AbstractArticlePDF–664K
9.
A Randomized, Phase III Study of Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab Investigating EGFR FISH in Patients with Advanced Non-Small Cell Lung Cancer: SWOG S0819
Roy S. Herbst, Mary W. Redman, Edward S. Kim, Thomas J. Semrad, Lyudmila Bazhenova, Gregory Masters, Kurt Oettel, Perry Guaglianone, Christopher Reynolds, Anand Karnad, Susanne M. Arnold, Marileila Varella-Garcia, James Moon, Philip C. Mack, Charles D. Blanke, Fred R. Hirsch, Karen Kelly, David R. Gandara
Lancet Oncol. Author manuscript; available in PMC 2019 Jan 1.
Published in final edited form as: Lancet Oncol. 2018 Jan; 19(1): 101–114. Published online 2017 Nov 20. doi: 10.1016/S1470-2045(17)30694-0
PMCID:
PMC5847342
AbstractArticlePDF–742K
10.
Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice – results from the ElderTac study
Wolfgang M. Brueckl, H. Jost Achenbach, Joachim H. Ficker, Wolfgang Schuette
BMC Cancer. 2018; 18: 333. Published online 2018 Mar 27. doi: 10.1186/s12885-018-4208-x
PMCID:
PMC5870245
AbstractArticlePDF–926K
11.
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
Kai-Lun Yu, Tzu-Hsiu Tsai, Chao-Chi Ho, Wei-Yu Liao, Ching-Kai Lin, Chia-Lin Hsu, Jin-Yuan Shih
Sci Rep. 2018; 8: 5837. Published online 2018 Apr 11. doi: 10.1038/s41598-018-24300-7
PMCID:
PMC5895614
AbstractArticlePDF–1020K
12.
Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing among Patients with Newly Diagnosed Metastatic Lung Cancer
Chan Shen, Kenneth L. Kehl, Bo Zhao, George R. Simon, Shouhao Zhou, Sharon H. Giordano
Clin Lung Cancer. Author manuscript; available in PMC 2018 Jul 1.
Published in final edited form as: Clin Lung Cancer. 2017 Jul; 18(4): e233–e241. Published online 2016 Nov 11. doi: 10.1016/j.cllc.2016.11.002
PMCID:
PMC5903454
AbstractArticlePDF–622K
13.
EGFR突变状态对Ⅲ期非鳞非小细胞肺癌患者放化疗近期疗效和长期生存的预测价值
李 付海, 白 桦, 李 夏南, 吴 梅娜, 余 荣, 石 安辉, 尹 丽, 王 洁, 朱 广迎
Zhongguo Fei Ai Za Zhi. 2011 Sep 20; 14(9): 715–718. Chinese. doi: 10.3779/j.issn.1009-3419.2011.09.03
PMCID:
PMC5999609
AbstractArticlePDF–1.4M
14.
晚期非小细胞肺癌表皮生长因子受体基因突变情况和其对吉非替尼疗效的影响
钟 巍, 王 孟昭, 李 龙芸, 夏 莹, 陈 闽江, 张 力, 赵 静
Zhongguo Fei Ai Za Zhi. 2012 Sep 20; 15(9): 513–520. Chinese. doi: 10.3779/j.issn.1009-3419.2012.09.03
PMCID:
PMC5999860
AbstractArticlePDF–1.2M
15.
Real world study of regimen containing bevacizumab as first‐line therapy in Chinese patients with advanced non‐small cell lung cancer
Puyuan Xing, Yuxin Mu, Yan Wang, Xuezhi Hao, Yixiang Zhu, Xingsheng Hu, Hongyu Wang, Peng Liu, Lin Lin, Zhijie Wang, Junling Li
Thorac Cancer. 2018 Jul; 9(7): 805–813. Published online 2018 May 16. doi: 10.1111/1759-7714.12650
PMCID:
PMC6026612
AbstractArticlePDF–561K
16.
超声气管镜针吸活检在肺癌诊断及基因检测中的作用
陈 闽江, 邵 池, 徐 燕, 孙 雪峰, 赵 静, 陈 勇, 赵 媛媛, 钟 巍, 王 孟昭
Zhongguo Fei Ai Za Zhi. 2018 Sep 20; 21(9): 670–676. Chinese. doi: 10.3779/j.issn.1009-3419.2018.09.04
PMCID:
PMC6137003
AbstractArticlePDF–1.5M
17.
Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer
Alessandro Russo, Tindara Franchina, Giuseppina Rosaria Rita Ricciardi, Caterina Fanizza, Antonino Scimone, Giuseppe Chiofalo, Antonio Giordano, Vincenzo Adamo
Oncotarget. 2017 Jan 31; 8(5): 8717–8725. Published online 2017 Jan 2. doi: 10.18632/oncotarget.14427
PMCID:
PMC5352435
AbstractArticlePDF–1.9M
18.
Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non–small-cell lung cancer in the USA
Yulin Li, Anita Appius, Thirupathi Pattipaka, Andrea Feyereislova, Adrian Cassidy, Apar Kishor Ganti
PLoS One. 2019; 14(1): e0209709. Published online 2019 Jan 4. doi: 10.1371/journal.pone.0209709
Correction in:
PLoS One. 2019; 14(2): e0212831.
PMCID:
PMC6319739
AbstractArticlePDF–1.2M
19.
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations
Francesco Passiglia, Federico Cappuzzo, Oscar Alabiso, Anna Cecilia Bettini, Paolo Bidoli, Rita Chiari, Carlotta Defferrari, Angelo Delmonte, Giovanna Finocchiaro, Guido Francini, Francesco Gelsomino, Diana Giannarelli, Monica Giordano, Alfonso Illiano, Lorenzo Livi, Olga Martelli, Clara Natoli, Gianfranco Puppo, Enrico Ricevuto, Elisa Roca, Daniele Turci, Domenico Galetta
Br J Cancer. 2019 Jan 8; 120(1): 57–62. Published online 2018 Oct 31. doi: 10.1038/s41416-018-0234-3
PMCID:
PMC6325128
AbstractArticlePDF–387K
20.
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
Alexandros Papachristofilou, Madeleine M. Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Christian Weiss, Miklos Pless, Richard Cathomas, Wolfgang Hilbe, Georg Pall, Thomas Wehler, Jürgen Alt, Helge Bischoff, Michael Geißler, Frank Griesinger, Karl-Josef Kallen, Mariola Fotin-Mleczek, Andreas Schröder, Birgit Scheel, Anke Muth, Tobias Seibel, Claudia Stosnach, Fatma Doener, Henoch S. Hong, Sven D. Koch, Ulrike Gnad-Vogt, Alfred Zippelius
J Immunother Cancer. 2019; 7: 38. Published online 2019 Feb 8. doi: 10.1186/s40425-019-0520-5
PMCID:
PMC6368815
AbstractArticlePDF–1.5M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center